Dorsavi Ltd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dorsavi Ltd with three other
companies in this sector in Australia:
Oncosil Medical Ltd
sales of 3.76 million Australian Dollars [US$2.92 million]
(4.22 million Australian Dollars [US$3.28 million]
of which 98%
was Cancer Immunotherapy), and
Starpharma Holdings Limited
(3.65 million Australian Dollars [US$2.84 million]
of which 100%
During the year ended June of 2017, sales at
Dorsavi Ltd were A$3.87 million (US$3.01 million).
increase of 19.7%
versus 2016, when the company's sales were A$3.24 million.
This was the fourth straight year of sales growth at Dorsavi Ltd.
Sales of Usa saw an increase
that was more than double the company's growth rate: sales were up
161.1% in 2017, from
A$453,802.00 to A$1.18 million.
Not all segments of Dorsavi Ltd experienced an increase in sales in 2017:
sales of Europe fell 7.2% to A$675,438.00 .
Dorsavi Ltd also experienced decreases in sales in
Australia (down 0.9% to A$2.04 million)